14 Best Biotech Stocks to Buy Right Now

Page 10 of 14

5. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Number of Hedge Fund Holders: 53

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best biotech stocks to buy. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) participated in the Bank of America Global Healthcare Conference 2025 on September 23. During the conference, the company presented a strategic review of its robust pipeline, encompassing both encouraging advancements and possible barriers.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported that it has five phase 3 initiatives in progress and is focusing on commercial launches for LifTrak, Casgevy, and Jurnavix. Patients with cystic fibrosis have begun utilizing LifTrak at a rapid rate, especially those with uncommon mutations. Meanwhile, Jurnavix has addressed the need for non-opioid pain management by gaining widespread coverage in the United States.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) also expects to surpass its upper-end operating expense forecast of $5 billion in 2025. The company attributes this to investments in external innovation, improved marketing for Jurnavix, and quicker enrollment in clinical trials.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a global biotechnology company that is involved in the discovery and development of small-molecule medications for the treatment of severe illnesses, including cystic fibrosis.

Page 10 of 14